New hope for tough psoriasis spots: tildrakizumab under the microscope
Disease control
Ongoing
This study looks at how well tildrakizumab works for psoriasis in areas that are often hard to treat, like the scalp, nails, genitals, and palms. About 120 adults with moderate to severe psoriasis will receive tildrakizumab and be followed for up to 52 weeks. The goal is to see i…
Sponsor: Clin4all • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC